We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GTBP market cap is 3.95M. The company's latest EPS is USD -5.3626 and P/E is -0.52.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.67M | -3.62M | -3.12M | -3.17M | -3.09M |
| Net Income | -227k | -1.99M | -2.42M | -2.96M | -2.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.46M | -6.76M | -57.52M | -21.26M | -13.58M |
| Net Income | -18.19M | -28.3M | -58.01M | -20.88M | -7.6M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 20.09M | 18.14M | 16.15M | 14.11M | 9.91M |
| Total Liabilities | 7.03M | 6.38M | 6.14M | 6.63M | 4.6M |
| Total Equity | 13.05M | 11.76M | 10.01M | 7.48M | 5.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 396k | 5.66M | 32.17M | 16.74M | 14.11M |
| Total Liabilities | 19.71M | 35.09M | 10.26M | 5M | 6.63M |
| Total Equity | -19.31M | -29.43M | 21.91M | 11.73M | 7.48M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.91M | -4.84M | -6.81M | -8.85M | -4.16M |
| Investing | -6.99M | -4.33M | -2.49M | -2.01M | 5.03M |
| Financing | 6.27M | 6.27M | 6.27M | 6.27M | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.66M | -7.26M | -15.61M | -15.22M | -8.85M |
| Investing | 200k | N/A | -23.04M | 12.15M | -2.01M |
| Financing | 3.43M | 12.53M | 42.32M | -224k | 6.27M |
| Market Cap | 3.95M |
| Price to Earnings Ratio | -0.52 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.66 |
| Price to Book Ratio | 0.53 |
| Dividend Yield | - |
| Shares Outstanding | 1.42M |
| Average Volume (1 week) | 12.48k |
| Average Volume (1 Month) | 55.04k |
| 52 Week Change | -66.96% |
| 52 Week High | 10.6599 |
| 52 Week Low | 2.60 |
| Spread (Intraday) | 0.18 (6.25%) |
| Company Name | GT Biopharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.gtbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
